Citigroup’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.6M Sell
1,112,622
-2,956,644
-73% -$49.6M 0.01% 751
2025
Q1
$62.5M Buy
4,069,266
+3,752,000
+1,183% +$57.7M 0.03% 364
2024
Q4
$6.99M Buy
317,266
+18,319
+6% +$404K ﹤0.01% 1175
2024
Q3
$5.39M Sell
298,947
-637,465
-68% -$11.5M ﹤0.01% 1289
2024
Q2
$15.2M Sell
936,412
-2,681,335
-74% -$43.6M 0.01% 734
2024
Q1
$51M Buy
3,617,747
+3,247,067
+876% +$45.8M 0.03% 331
2023
Q4
$3.87M Sell
370,680
-35,804
-9% -$374K ﹤0.01% 1261
2023
Q3
$4.15M Sell
406,484
-328,347
-45% -$3.35M ﹤0.01% 1129
2023
Q2
$5.53M Sell
734,831
-4,060,549
-85% -$30.6M ﹤0.01% 1047
2023
Q1
$42.4M Buy
4,795,380
+4,043,784
+538% +$35.8M 0.03% 340
2022
Q4
$6.85M Sell
751,596
-458,241
-38% -$4.18M 0.01% 945
2022
Q3
$9.76M Sell
1,209,837
-3,468,047
-74% -$28M 0.01% 815
2022
Q2
$35.2M Buy
4,677,884
+4,398
+0.1% +$33.1K 0.03% 365
2022
Q1
$43.9M Sell
4,673,486
-1,032,819
-18% -$9.7M 0.03% 380
2021
Q4
$45.7M Buy
5,706,305
+3,620,439
+174% +$29M 0.02% 388
2021
Q3
$20.3M Sell
2,085,866
-1,866,840
-47% -$18.2M 0.01% 688
2021
Q2
$39.1M Buy
3,952,706
+1,527,717
+63% +$15.1M 0.02% 468
2021
Q1
$28M Sell
2,424,989
-688,300
-22% -$7.94M 0.02% 568
2020
Q4
$30M Sell
3,113,289
-6,203
-0.2% -$59.9K 0.02% 512
2020
Q3
$28.1M Sell
3,119,492
-96,690
-3% -$871K 0.02% 464
2020
Q2
$39.7M Buy
3,216,182
+217,097
+7% +$2.68M 0.03% 298
2020
Q1
$26.9M Buy
2,999,085
+103,238
+4% +$927K 0.02% 345
2019
Q4
$28.4M Buy
2,895,847
+164,963
+6% +$1.62M 0.02% 442
2019
Q3
$18.8M Sell
2,730,884
-714,437
-21% -$4.92M 0.01% 547
2019
Q2
$31.8M Sell
3,445,321
-666,134
-16% -$6.15M 0.03% 401
2019
Q1
$64.5M Buy
4,111,455
+2,071,417
+102% +$32.5M 0.06% 171
2018
Q4
$31.5M Sell
2,040,038
-2,951,725
-59% -$45.5M 0.03% 329
2018
Q3
$108M Sell
4,991,763
-576,844
-10% -$12.4M 0.1% 102
2018
Q2
$135M Buy
5,568,607
+3,987,104
+252% +$97M 0.12% 77
2018
Q1
$27M Sell
1,581,503
-547,112
-26% -$9.35M 0.02% 352
2017
Q4
$40.3M Buy
2,128,615
+207,530
+11% +$3.93M 0.03% 264
2017
Q3
$33.8M Buy
1,921,085
+736,602
+62% +$13M 0.03% 292
2017
Q2
$39.4M Sell
1,184,483
-348,057
-23% -$11.6M 0.04% 244
2017
Q1
$49.2M Buy
1,532,540
+661,269
+76% +$21.2M 0.04% 208
2016
Q4
$31.6M Sell
871,271
-162,829
-16% -$5.9M 0.03% 284
2016
Q3
$47.6M Buy
1,034,100
+848,209
+456% +$39M 0.04% 179
2016
Q2
$9.34M Sell
185,891
-38,723
-17% -$1.95M 0.01% 537
2016
Q1
$12M Sell
224,614
-27,642
-11% -$1.48M 0.01% 449
2015
Q4
$16.6M Sell
252,256
-133,581
-35% -$8.77M 0.02% 410
2015
Q3
$21.8M Buy
385,837
+38,835
+11% +$2.19M 0.02% 337
2015
Q2
$20.5M Buy
347,002
+89,312
+35% +$5.28M 0.02% 371
2015
Q1
$16.1M Sell
257,690
-81,543
-24% -$5.08M 0.02% 440
2014
Q4
$19.5M Buy
339,233
+25,463
+8% +$1.46M 0.02% 371
2014
Q3
$16.9M Sell
313,770
-61,362
-16% -$3.3M 0.01% 406
2014
Q2
$19.7M Buy
375,132
+87,321
+30% +$4.58M 0.02% 401
2014
Q1
$15.2M Sell
287,811
-2,051,054
-88% -$108M 0.02% 441
2013
Q4
$93.7M Buy
2,338,865
+1,679,676
+255% +$67.3M 0.08% 107
2013
Q3
$24.9M Buy
659,189
+265,866
+68% +$10M 0.02% 320
2013
Q2
$15.4M Buy
+393,323
New +$15.4M 0.02% 439